Medical

5-alpha-reductase inhibitors

5-α-re·duc·tase in·hib·i·tors

(rĕ-dŭk'tās in-hib'i-tŏrz)
Drugs that inhibit the action of 5α-reductase, resulting in lower levels of prostatic dihydrotestosterone, produced by the enzyme from testosterone as the primary androgen in the prostate.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
Mentioned in
References in periodicals archive
A team led by Edinburgh University and University College London studied about 55,000 men in the UK, who had been prescribed 5-alpha-reductase inhibitors over an 11-year period.
5-alpha-reductase inhibitors (5-ARIs) are a totally different kind of drug, which shrink the glandular tissue of the prostate, reducing its bulk to eventually reduce constriction by the prostate as well.
1).[sup.4] The mainstay of medical treatments includes alpha-blockers, 5-alpha-reductase inhibitors (5-ARIs), or a combination of the two.
First-line therapies indude alpha-1 adrenergic receptor antagonists (alpha-blockers) and 5-alpha-reductase inhibitors (5-AR1s).
Exclusion criteria also included: consumption of food rich in soy isoflavonoids, dietary supplements of any kind, medication with possible effects on prostate health such as antibiotics, anti-inflammatory drugs, alpha-1 -adrenoreceptor antagonist and 5-alpha-reductase inhibitors.
Cancer chemopreventive approaches may include 5-alpha-reductase inhibitors, histone deacetylase inhibitors, antioxidans, non-steroidal anti-inflammatory drugs, cholesterol-lowering statins, vitamin D analogues.
FDA-approved conventional medications used to treat BPH are of two categories, alpha-antagonists and 5-alpha-reductase inhibitors.
Adverse side effects of 5-alpha-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.
Patients were excluded if they had used 5-alpha-reductase inhibitors, if they had undergone prior prostate surgery, had a prior diagnosis of prostate cancer, had used androgen ablative therapies, had evidence of prostatitis, or if they were allergic to fluoroquinolones.
Drugs known as 5-alpha-reductase inhibitors like finasteride (Proscar) are widely used to treat benign prostatic hyperplasia (enlarged prostate).
Medications called 5-alpha-reductase inhibitors (Proscar, for example) help shrink the prostate.
Previous treatment with 5-alpha-reductase inhibitors was not allowed and alpha-blockers were discontinued at least 14 days prior to study.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.